Bullet Ban Gone After Ratcliffe Letter to Bureau of Alcohol, Tobacco, Firearms and Explosives
Mar 11, 2015 | 2727 views | 0 0 comments | 30 30 recommendations | email to a friend | print

Washington, D.C. – The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) announced that it will abandon its plan to ban a widely-used bullet used for the AR-15, the most popular sporting rifle in the United States. U.S. Rep. John Ratcliffe (R-TX) Issued the following statement:

“In a recent survey of my constituents, 85 percent said that they disagreed with the president's back door bullet ban. After putting the pressure on the Obama administration, we learned that they will abandon this attempted infringement upon our Second Amendment rights. I heard my constituents’ voices, and it mattered. The overwhelming opposition of my constituents to this proposed ban helped me convince colleagues to take a united stand against this constitutional overreach. As a member of the House Judiciary Committee, I will continue to be the first line of defense for safeguarding the Constitution and holding the Obama administration in check. We cannot allow the president to circumvent the Constitution and attempt to write laws on his own. I believe I was sent to Congress to defend the Constitution, not rubber stamp its abuse.“

Last week, John Ratcliffe and other Members of Congress sent a letter to ATF Director B. Todd Jones expressing strong concern about the Obama administration’s plan to ban the manufacture and importation of the second-most common ammunition used for the AR-15, the M855 or “green tip.” The letter and list of Members who signed it can be found here.

Americans own more than 5 million AR-15s, which are the most commonly used rifles for sports shooting as well as home protection. The ammunition used for the AR-15 has been exempted under federal law for sporting purposes for over 30 years, which allows it to be lawfully manufactured, imported, and sold on the civilian market in the United States.

Comments-icon Post a Comment
No Comments Yet